Roivant Sciences (NASDAQ:ROIV) focuses on applying technology to drug development, aiming to quickly and efficiently bring innovative medicines to patients. The company operates by building "Vants" - nimble, entrepreneurial biotech and healthcare technology companies equipped with cutting-edge technology to tackle various medical and logistical challenges. Roivant's projects span multiple therapeutic areas including rare diseases, oncology, immunology, and neuroscience, with the goal of improving health outcomes and reducing the time and cost of drug development processes. By leveraging its proprietary technology platforms and strategic partnerships, Roivant aims to deliver a diverse pipeline of promising treatments that address unmet medical needs, simplifying healthcare delivery and accessibility for patients worldwide.